ea0041oc7.3 | Cardiovascular endocrinology | ECE2016
Berr Christina M
, Quinkler Marcus
, Stieg Mareike
, Deutschbein Timo
, Osswald Andrea
, Schmidmaier Ralf
, Reisch Nicole
, Ritzel Katrin
, Blaser Rainer
, Fassnacht Martin
, Stalla Gunter
, Beuschlein Felix
, Reincke Martin
Background: Endogenous Cushings syndrome (CS) is rare with an estimated yearly incidence of 13 patients/million. CS describes a group of diseases that have in common an excess secretion of glucocorticoids which results in a characteristic clinical phenotype. Severe courses of Cushings syndrome are characterized by a break-down of protein catabolism translating into clinical consequences including muscle weakness. While remission of CS is achievable by surgica...